Stock listing

TPEx:4174 OBI Pharma, Inc. (浩鼎) 股價

Follow OBI Pharma, Inc. into a list and get an email when it puts out news.

Share price · TPEX:4174

$64.00 TWD -13.50 (-17.4%)

Close on Nov 20, 2026

Past year +8.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$62.90 – $66.60 TWDNov 20, 2026
Volume
933,477 sharesNov 20, 2026
Market cap
$8.52B TWDAt the close on Nov 20, 2026 · price × 133.1M shares outstanding
52-week range
$24.30 – $83.00 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$56.12M TWDMedian day 766,674 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
OBI Pharma, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:4174 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$64.00-13.50-17.4%$64.00$66.60$62.90933,477
$77.50-0.90-1.1%$83.00$83.00$74.002,794,592
$78.40+7.10+10.0%$78.40$78.40$78.40339,144
$71.30+6.40+9.9%$71.30$71.30$71.30404,001
$64.900.000.0%$64.90$64.90$64.900
$64.90+4.40+7.3%$62.20$66.50$60.105,207,384
$60.50+5.50+10.0%$55.10$60.50$55.103,271,468
$55.00+1.60+3.0%$55.00$58.60$55.002,721,220
$53.40+4.85+10.0%$49.45$53.40$49.00894,766
$48.55+1.60+3.4%$44.35$49.85$43.001,835,990
$46.95+0.85+1.8%$47.40$50.30$45.901,266,563
$46.10-1.20-2.5%$48.15$48.95$45.00789,093
$47.30+0.20+0.4%$46.75$48.25$46.05563,173
$47.10+1.70+3.7%$45.40$48.05$45.40609,921
$45.40-3.10-6.4%$47.60$48.25$45.001,051,811
$48.50-0.45-0.9%$48.05$50.50$48.00709,646
$48.95-3.25-6.2%$51.40$52.60$48.301,013,718
$52.20+1.699+3.4%$53.80$53.80$51.10516,879
$50.50-0.499-1.0%$50.50$50.50$50.500
$51.00-2.50-4.7%$54.00$54.00$51.00641,773
$53.50+0.90+1.7%$53.10$56.50$53.10897,825
$52.600.000.0%$53.00$54.50$51.00951,356
$52.60-4.30-7.6%$56.40$57.30$51.801,718,783
$56.90-3.00-5.0%$59.90$59.90$54.202,738,888
$59.90+0.20+0.3%$59.70$61.00$57.40867,342
$59.70+3.90+7.0%$59.80$59.80$57.50756,645
$55.80-1.70-3.0%$56.90$57.60$54.00776,702
$57.50+3.80+7.1%$57.90$58.90$56.001,327,126
$53.70+1.60+3.1%$52.00$54.00$50.001,062,500
$52.10+1.30+2.6%$50.80$54.30$50.802,276,944
$50.80+4.60+10.0%$46.15$50.80$45.853,317,903
$46.20+4.20+10.0%$45.00$46.20$43.101,898,940
$42.00-1.10-2.6%$45.60$45.60$40.105,902,618
$43.10+3.90+9.9%$43.10$43.10$43.101,163,952
$39.20+3.55+10.0%$39.00$39.20$38.551,189,785
$35.65+3.20+9.9%$32.65$35.65$32.451,506,241
$32.45-0.15-0.5%$33.00$34.15$32.053,313,778
$32.60+2.95+9.9%$29.25$32.60$29.002,870,409
$29.65-0.25-0.8%$29.90$31.05$29.002,047,649
$29.90+2.70+9.9%$27.75$29.90$27.701,183,085
$27.20-0.55-2.0%$27.55$29.30$27.203,467,507
$27.75+1.10+4.1%$26.95$28.35$26.80677,000
$26.65+0.65+2.5%$26.60$26.65$25.85241,051
$26.00+0.90+3.6%$25.10$26.25$25.10382,787
$25.10-0.35-1.4%$25.40$25.40$24.80375,297
$25.45-0.70-2.7%$25.90$25.90$25.40205,500
$26.15-0.30-1.1%$26.30$26.30$25.85263,057
$26.45+0.45+1.7%$26.35$27.00$26.15597,669
$26.00+1.05+4.2%$25.35$26.35$25.00588,500
$24.95-0.10-0.4%$25.10$25.30$24.90305,092
$25.05+0.45+1.8%$24.35$25.50$24.30546,500
$24.60-0.40-1.6%$25.45$25.45$24.60487,138
$25.00-0.05-0.2%$25.30$25.40$24.85236,455
$25.05-0.35-1.4%$25.50$25.50$24.90462,101
$25.40-0.75-2.9%$26.05$26.05$25.35451,500
$26.15-0.25-0.9%$26.50$26.50$26.10191,500
$26.40-0.30-1.1%$26.55$26.80$26.35163,038
$26.70+0.60+2.3%$26.30$26.90$26.30276,500
$26.10-0.20-0.8%$26.60$26.60$25.85215,215
$26.30-0.60-2.2%$26.80$27.00$26.25197,008
$26.900.000.0%$27.35$27.40$26.60243,577
$26.90+1.30+5.1%$26.45$27.30$26.30567,178

Splits

1 split · TPEX:4174 · every price before a split is adjusted for it

DayRatioWhat
1-for-2Consolidation
Ticker
TPEx:4174
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TPEx
Currency
TWD

What changed lately

Latest news

All OBI Pharma, Inc. news

OBI Pharma, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
1 in the last 12 months · 20 in all · newest Jan 12, 2026 · oldest 2022
Decks
16 decks · latest Jun 26, 2026

Valuation

EV/sales 154× against a median of 6.3×: the highest of 4 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$8.02B TWD
P/E
Loss
EV/sales
154×
EV/EBITDA
Negative EBITDA
Price/book
5.7×
Gross margin
−152.6%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
OBI Pharma, Inc. · TPEX:4174US$258.5MUS$243.4Mn/a154×n/a5.7×n/a0.0×n/a
Kyverna Therapeutics, Inc. · NASDAQ:KYTXUS$263.5MUS$117.8Mn/an/an/a2.0×n/a0.2×2.02
PepGen Inc. · NASDAQ:PEPGUS$261.8MUS$172.6Mn/an/an/a2.5×n/a0.1×1.11
Ocugen, Inc. · NASDAQ:OCGNUS$260.6MUS$178.1Mn/a37.3×n/an/an/an/a1.47
Altimmune, Inc. · NASDAQ:ALTUS$258.8MUS$28.73Mn/an/an/a0.6×n/a0.1×1.55
Prelude Therapeutics Incorporated · NASDAQ:PRLDUS$258.6MUS$136.2Mn/a6.3×n/a2.1×−247.1%0.1×1.48
TransThera Sciences (Nanjing). Inc. · HKEX:2617US$257.1MUS$119.4Mn/an/an/a2.0×n/a0.0×n/a
Eikon Therapeutics, Inc. · NASDAQ:EIKNUS$256.8MUS$44.67Mn/an/an/a0.7×n/a0.7×1.91
SAB Biotherapeutics, Inc. · NASDAQ:SABSUS$255.7MUS$156.5Mn/an/an/a1.2×n/a0.0×1.19
Evommune, Inc. · NYSE:EVMNUS$255.5MUS$86.86Mn/an/an/a1.0×n/a0.0×0.96
Editas Medicine, Inc. · NASDAQ:EDITUS$253.1MUS$119.7Mn/a2.4×n/a3.0×−144.9%0.7×2.22
Median of the othersUS$257.9MUS$119.6M6.3×2.0×−196.0%0.1×1.48

Team and board

DirectorRole
Kung-Yee LiangChairman
Chin-Ting ChiuIndependent Director
Howard S. LeeIndependent Director
Pao-Hsun WangDirector
TAI-TSANG CHENIndependent Director
Wan-Fang TingDirector
Yeong-Fang ChiangVice Chairman

Events

QuarterResultsShare move
Q4 2022Mar 13, 2023 · Before open−0.9%
Q1 2022May 6, 2022 · Before open+3.0%
Q4 2021Mar 18, 2022 · After close−0.5%
Q3 2021Nov 5, 2021 · Before open+0.5%
Quarter to Jun 30, 2021Aug 6, 2021 · Before open+1.4%
Quarter to Mar 31, 2021May 7, 2021 · After close0.0%

Open Events

Decks

DeckKindSlidesDate
Shareholder Meeting (June 2026)Shareholder meeting16 slidesJun 26, 2026
Investor Presentation (December 2025)Investor deck34 slidesDec 18, 2025
Investment Summit of BIO Asia-Taiwan 2025Conference12 slidesJul 1, 2025
Shareholder Meeting (June 2025)Shareholder meeting28 slidesJune 2025
Investor Presentation (December 2024)Investor deck33 slidesDec 2, 2024
2024 BioAsia – Investment SummitConference9 slidesJul 25, 2024
Shareholder Meeting (June 2024)Shareholder meeting36 slidesJun 17, 2024
Investor Presentation (December 2023)Investor deck47 slidesDec 6, 2023
Investor Presentation (December 2023)Investor deck47 slidesDec 6, 2023
Shareholder Meeting (June 2023)Shareholder meeting41 slidesJun 27, 2023
All 16 decks
DeckKindSlidesDate
QIC CEO Week 2023Conference51 slidesApr 25, 2023
Investor Presentation (October 2022)Investor deck45 slidesOct 12, 2022
Shareholder Meeting (June 2022)Shareholder meeting56 slidesJun 27, 2022
QIC Healthcare Forum 2022Conference49 slidesFeb 16, 2022
Investor Presentation (November 2021)Investor deck40 slidesNov 11, 2021
39th Annual J.P. Morgan Healthcare Virtual Conference (January 2021)Conference45 slidesJan 11, 2021

Open Decks

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue58.6M62.7M41.5M4.71M18.8M140.9M872.0K13.3M376.0K92.4M
Cost of revenue136.1M139.0M115.0M44.9M44.4M6.47M226.3M5.29M67.3M45.4M
Gross profit-77.5M-76.3M-73.5M-40.1M-25.6M134.4M-225.5M8.05M-66.9M47.0M
Research and development1.73B1.97B1.70B1.77B1.45B1.31B1.18B1.13B848.7M859.5M
Selling, general and administrative362.0M326.8M319.3M309.8M240.8M290.4M267.5M308.7M341.3M345.4M
Operating income-2.17B-2.37B-2.09B-1.91B-1.74B-1.49B-1.44B-1.43B-1.19B-1.11B
Depreciation and amortization227.2M222.3M249.0M246.6M216.3M231.8M167.4M122.6M67.3M45.4M
EBITDA-1.94B-2.15B-1.84B-1.67B-1.52B-1.26B-1.28B-1.31B-1.12B-1.07B
Interest expense13.1M10.7M7.94M3.99M3.80M4.18M2.71M1.67M1.20M213.0K
Income before tax-2.26B-2.50B-1.28B-1.92B-1.74B-1.49B-1.45B-1.26B-1.38B-1.11B
Income tax-9.59M-17.8M-24.4M-3.79M-5.59M-6.31M1.98M2.50M
Net income-2.05B-2.31B-1.27B-1.90B-1.72B-1.49B-1.44B-1.22B-1.38B-1.11B
Earnings per share, basic-15.45-17.40-5.53-8.55-8.55-7.43-7.43-6.99-7.91-6.39

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents759.3M1.73B899.3M4.74B2.51B3.34B4.55B3.66B2.56B1.41B
Short-term investments427.0M1.40B1.88B31.5M141.8M383.5M1.39M2.02B2.36B
Receivables10.3M4.20M30.1M28.3M23.3M19.0M40.0M38.1M60.5M40.8M
Inventory18.4M27.7M25.9M22.0M9.56M7.36M4.20M1-60.5M-40.8M
Current assets1.58B3.44B3.16B5.03B2.85B3.89B4.71B3.79B4.71B3.88B
Property, plant and equipment1.18B1.15B918.2M866.0M235.4M234.6M226.6M
Goodwill61.1M61.1M61.1M61.1M61.1M
Total assets3.42B5.65B5.60B6.63B4.49B5.34B5.66B4.71B5.19B6.33B
Accounts payable985.0K2.90M773.0K1.14M525.0K157.0K177.0K
Current liabilities350.6M412.4M158.6M221.1M327.2M248.5M200.0M103.8M68.7M97.5M
Long-term debt29.5M48.2M14.0M21.0M28.0M35.0M43.3M52.1M61.0M69.9M
Total debt501.1M247.1M293.0M237.0M178.3M62.0M71.0M80.0M
Total liabilities696.1M833.4M650.4M497.6M615.9M502.1M459.1M236.0M129.7M167.3M
Shareholders' equity1.89B3.81B3.81B4.63B2.72B4.23B5.10B4.35B5.06B6.16B
Shares outstanding132.9M132.8M229.1M222.1M201.0M200.6M193.7M174.8M174.4M173.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-2.02B-1.83B-1.65B-1.62B-1.06B-1.61B-1.05B-864.3M-1.11B-840.1M
Capital spending-48.3M-119.6M-108.2M-300.6M-245.2M-185.6M-51.6M-20.8M-152.4M-183.4M
Free cash flow-2.07B-1.95B-1.76B-1.92B-1.31B-1.80B-1.10B-885.1M-1.26B-1.02B
Cash from investing-169.9M82.7M-195.9M-78.7M1.98B2.22B95.6M
Cash from financing607.1M4.01B163.7M283.1M1.99B-7.50M27.0M-140.9M
Share buybacks0-93.5M0-386.7M
Change in cash-972.7M832.8M-3.84B2.23B-826.1M-1.52B886.5M1.11B1.14B-886.5M

Open Financials

Cap table

Built by 6ix from OBI Pharma, Inc.’s releases

Common shares
133,104,749
Fully diluted
133,104,749

Fully diluted

LineShares
Common shares133,104,749

Share count over time

CountShares
Nov 22, 2026133,104,749

Open Cap table

Shareholders

Register

HolderSharesOf the companyAs of
宜泰投資股份有限公司12.9M9.8%Oct 31, 2026
李威漢47,4180.04%Oct 31, 2026
陳雅琪37,5000.03%Oct 31, 2026
黃鐙毅20,5000.02%Oct 31, 2026
莊若晨5,000<0.01%Sep 30, 2026
Chen,tai—tsang00.00%Oct 31, 2026
曹菁華00.00%Oct 31, 2026
邱欽庭00.00%Oct 31, 2026
莊佳甄00.00%Oct 31, 2026
丁琬芳00.00%Oct 31, 2026
All 14 holders
HolderSharesOf the companyAs of
李世仁00.00%Oct 31, 2026
王保勳00.00%Oct 31, 2026
蔣永芳00.00%Oct 31, 2026
梁賡義00.00%Oct 31, 2026

Funds

HolderSharesValueAs of
Vanguard Total International Stock Index Fund1.27MUS$978KJul 31, 2026
Vanguard Emerging Markets Stock Index Fund1.19MUS$918KJul 31, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund354KUS$274KJul 31, 2026
Emerging Markets Core Equity 2 Portfolio81,000US$62,592Jul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF76,000US$59,024Jul 31, 2026
Vanguard Total World Stock Index Fund63,843US$49,334Jul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF56,000US$43,491Jul 31, 2026
The Emerging Markets Small Cap Series51,000US$39,410Jul 31, 2026
Emerging Markets ex China Core Equity Portfolio17,000US$13,137Jul 31, 2026
Vanguard ESG International Stock ETF15,494US$14,148May 31, 2026
All 11 holders
HolderSharesValueAs of
World ex U.S. Core Equity Portfolio13,500US$10,432Jul 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Chin-Ting ChiuIndependent Director · Since at least Nov 5, 2026
Howard S. LeeIndependent Director · Since at least Nov 5, 2026
Kung-Yee LiangChairman · Since at least Nov 5, 2026
Pao-Hsun WangDirector · Since at least Nov 5, 2026
TAI-TSANG CHENIndependent Director · Since at least Nov 5, 2026
Wan-Fang TingDirector · Since at least Nov 5, 2026
Yeong-Fang ChiangVice Chairman · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about OBI Pharma, Inc.